The Plain Record

Neutral daily news — clear headlines, complete facts.

National

Lord Cameron Urges Increased NHS Access to Alzheimer’s Treatments

Lord David Cameron called for NHS access to Alzheimer’s drugs and a 18-week diagnostic cap following the death of his mother from the disease.

Background: Executive orders and what they can do

Published November 14, 2026 at 3:44 AM EST

The short answer

Lord David Cameron called for NHS access to Alzheimer’s drugs and a 18-week diagnostic cap following the death of his mother from the disease. Former Prime Minister Lord David Cameron has called on Health Secretary Andy Burnham to increase NHS access to new Alzheimer’s treatments following the death of his mother, Mary Cameron, from the disease in 2025.

Lord Cameron Urges Increased NHS Access to Alzheimer’s Treatments

The Facts

Who
Lord David Cameron, Andy Burnham, Alzheimer’s Research UK, Department of Health and Social Care
What
Advocacy for Alzheimer's treatment access and social care reform
When
Saturday, November 14, 2026
Where
United Kingdom
Why
To accelerate the approval and delivery of dementia treatments and reform the funding of long-term social care.

Former Prime Minister Lord David Cameron has called on Health Secretary Andy Burnham to increase NHS access to new Alzheimer’s treatments following the death of his mother, Mary Cameron, from the disease in 2025. In an interview with the Telegraph, Lord Cameron described his mother’s final years, stating she was aware of her cognitive decline and repeatedly asked his sister to end her life. Lord Cameron, who serves as president of Alzheimer’s Research UK, is advocating for the approval of drugs previously rejected for National Health Service (NHS) use and a maximum 18-week wait for dementia diagnoses.

The appeal comes as a new clinical trial, the Alzheimer’s disease Systematic Multi-arm Adaptive Randomised Trial (Ad-Smart), seeks to reduce the time required to test treatments by more than half. While drugs such as lecanemab and donanemab were licensed in 2024, they are currently only available to patients through clinical trials rather than routine NHS care. The National Institute for Health and Care Excellence (NICE), which evaluates the cost-effectiveness of medicines, is currently reviewing these treatments.

Lord Cameron also addressed the broader issue of social care funding, expressing regret that his government did not implement a cap on care costs. He proposed a government-backed insurance system, similar to models used for terrorism insurance, to protect families from catastrophic long-term care bills. He noted that while only a small percentage of households face such extreme costs, the financial impact on those affected is significant.

The scale of the government's current response involves a £33 million investment through the Dame Barbara Windsor Dementia Goals programme. This funding is intended to increase recruitment for clinical studies, which may eventually lead to more widely available treatments. For a typical household, the impact of these decisions is reflected in the high cost of private care versus the potential for a state-regulated insurance or cap system. A government-backed insurance model could shift the financial burden of long-term care away from individual families who currently face the possibility of losing their primary assets to pay for nursing services.

What happens next depends on the independent assessments by NICE and the findings of Baroness Casey’s commission on social care reform. The Department of Health and Social Care is currently developing a Modern Service Framework for Frailty and Dementia and plans to appoint a national dementia tsar to oversee improvements in care quality. A specific timeline for the conclusion of the NICE evaluations or the implementation of the new National Care Service has not been reported, though the government stated it is bringing forward the commission’s timetable.

Timeline of what happened

Key dates and decisions, in the order they occurred.

  1. January 1, 2024

    Lecanemab and donanemab licensed for use

  2. January 1, 2025

    Mary Cameron dies from Alzheimer’s disease

  3. October 1, 2026

    Government announces trial to speed up treatment discovery

  4. November 14, 2026

    Lord Cameron interview published detailing mother’s experience

Summaries are written by The Plain Record to state the facts of a story plainly and without political slant. Drafted with AI assistance and checked against the source record before publication. See how we report, or report a correction.

← Back to the front page

Questions readers ask

What happened: Lord Cameron Urges Increased NHS Access to Alzheimer’s Treatments?

Former Prime Minister Lord David Cameron has called on Health Secretary Andy Burnham to increase NHS access to new Alzheimer’s treatments following the death of his mother, Mary Cameron, from the disease in 2025. In an interview with the Telegraph, Lord Cameron described his mother’s final years, stating she was aware of her cognitive decline and repeatedly asked his sister to end her life.

Who is involved?

Lord David Cameron, Andy Burnham, Alzheimer’s Research UK, Department of Health and Social Care

When did this happen?

Saturday, November 14, 2026

Where did this happen?

United Kingdom

Why does this matter?

To accelerate the approval and delivery of dementia treatments and reform the funding of long-term social care.